Interleukin-17 and lipopolysaccharides synergistically induce cyclooxygenase-2 expression in human intestinal myofibroblasts

Journal of Gastroenterology and Hepatology (Australia)

Volumn 20, Issue 4, 2005, Pages 619-627

  Zhang, Zhuobin ^a   Andoh, Akira ^a   Inatomi, Osamu ^a   Bamba, Shigeki ^a   Takayanagi, Atsushi ^b   Shimizu, Nobuyoshi ^b   Fujiyama, Yoshihide ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bacteria; Cytokine; Cytoprotection; IBD

Indexed keywords

COMPLEMENTARY DNA; CYCLOOXYGENASE 2; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; MESSENGER RNA; PROSTAGLANDIN E2; RECOMBINANT INTERLEUKIN 17; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ADENOVIRUS; ARTICLE; CELL CULTURE; COLON; CONTROLLED STUDY; ENTERITIS; GENE EXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; INFLAMMATION; INTESTINE; INTESTINE MUCOSA; MYOFIBROBLAST; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS RECOMBINANT; WESTERN BLOTTING;

EID: 19944415576     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2004.03748.x     Document Type: Article

References (39)

1. Singer II, Kawka DW, Schloemann S, Tessner T, Riehl T, Stenson WF. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 1998; 115: 297-306.
2. Mitchell JA, Larkin S, Williams TJ. Cyclooxygenase-2: regulation and relevance in inflammation. Biochem. Pharmacol. 1995; 50: 1535-42.
3. Smith WL, Dewitt DL. Prostaglandin endoperoxide H synthases-1 and -2. Adv. Immunol. 1996; 62: 167-215.
4. Mifflin RC, Saada JI, Di Mari JF, Adegboyega PA, Valentich JD, Powell DW. Regulation of COX-2 expression in human intestinal myofibroblasts: mechanisms of IL-1-mediated induction. Am. J. Physiol. Cell Physiol. 2002; 282: C824-34.
5. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998; 115: 182-205.
6. Tabernero A, Reimund JM, Chasserot S, Muller CD, Andriantsitohaina R. Cyclooxygenase-2 expression and role of vasoconstrictor prostanoids in small mesenteric arteries from patients with Crohn's disease. Circulation 2003; 107: 1407-10.
7. Hendel J, Nielsen OH. Expression of cyclooxygenase-2 mRNA in active inflammatory bowel disease. Am. J. Gastroenterol. 1997; 92: 1170-3.
8. Berg DJ, Zhang J, Weinstock JV et al. Rapid development of colitis in NSAID-treated IL-10-deficient mice. Gastroenterology 2002; 123: 1527-42.
9. Felder JB, Korelitz BI, Rajapakse R, Schwarz S, Horatagis AP, Gleim G. Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study. Am. J. Gastroenterol. 2000; 95: 1949-54.
10. Biancone L, Tosti C, De Nigris F, Fantini M, Pallone F. Selective cyclooxygenase-2 inhibitors and relapse of inflammatory bowel disease. Gastroenterology 2003; 125: 637-8.
11. Kunkel SL, Spengler M, May MA, Spengler R, Larrick J, Remick D. Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. J. Biol. Chem. 1988; 263: 5380-4.
12. Strassmann G, Patil-Koota V, Finkelman F, Fong M, Kambayashi T. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J. Exp. Med. 1994; 180: 2365-70.
13. Janabi N, Hau I, Tardieu M. Negative feedback between prostaglandin and alpha- and beta-chemokine synthesis in human microglial cells and astrocytes. J. Immunol. 1999; 162: 1701-6.
14. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB. Myofibroblasts, II. Intestinal subepithelial myofibroblasts. Am. J. Physiol. 1999; 277: C183-201.
15. Okuno T, Andoh A, Bamba S et al. Interleukin-1beta and tumor necrosis factor-alpha induce chemokine and matrix metalloproteinase gene expression in human colonic subepithelial myofibroblasts. Scand. J. Gastroenterol. 2002; 37: 317-24.
16. Reuter BK, Asfaha S, Buret A, Sharkey KA, Wallace JL. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. J. Clin. Invest. 1996; 98: 2076-85.
17. Oshima M, Dinchuk JE, Kargman SL et al. Suppression of intestinal polyposis in Ape delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996; 87: 803-9.
18. Fossiez F, Banchereau J, Murry R, van Kooten C, Garrone P, Lebecque S. Interleukin-17. Intern. Rev. Immunol. 1998; 16: 541-51.
19. - T cells. J. Interferon Cytokine Res. 1996; 16: 611-17.
20. Fussiez F, Djossou O, Chomarat P et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 1996; 183: 2593-603.
21. Chabaud M, Fossiez F, Taupin JL, Miossec P. Enhancing effects of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J. Immunol. 1998; 161: 409-14.
22. Cai XY, Gommol-CP J, Justice L, Narula SK, Fine JS. Reglation of granulocyte colony-stimulating factor gene expression by interleukin-17. Immunol. Lett. 1998; 62: 51-8.
23. Shimada M, Andoh A, Hata K et al. IL-6 secretion by human pancreatic periacinar myofibroblasts in response to inflammatory mediators. J. Immunol. 2002; 168: 861-8.
24. Hata K, Andoh A, Shimada M et al. IL-17 stimulates inflammatory responses via NF-kappaB and MAP kinase pathways in human colonic myofibroblasts. Am. J. Physiol. Gastrointest. Liver Physiol. 2002; 282: G1035-44.
25. Fujino S, Andoh A, Bamba S et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003; 52: 65-70.
26. Mahida YR, Beltinger J, Marh S et al. Adult human colonic subepithelial myofibroblasts express extracellular matrix proteins and cyclooxygenase-1 and -2. Am. J. Physiol. 1997; 273: G1341-8.
27. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987; 162: 156-9.
28. Andoh A, Takaya H, Saotome T et al. Cytokine regulation of chemokine (IL-8, MCP-1, and RANTES) gene expression in human pancreatic periacinar myofibroblasts. Gastroenterology 2000; 119: 211-19.
29. Funk CD, Funk LB, Kennedy ME, Pong AS, Fitzgerald GA. Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB J. 1991; 5: 2304-12.
30. Hla T, Neilson K. Human cyclooxygenase-2 cDNA. Proc. Natl Acad. Sci. USA 1992; 89: 7384-8.
31. Ogawa A, Andoh A, Araki Y, Bamba T, Fujiyama Y. Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin. Immunol. 2004; 110: 55-62.
32. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc. Natl Acad. Sci. USA 1977; 74: 5463-7.
33. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983; 11: 1475-89.
34. Obara H, Takayanagi A, Hirahashi J et al. Overexpression of truncated IkappaBalpha induces TNF-alpha-dependent apoptosis in human vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 2000; 20: 2198-204.
35. Podolsky DK. Inflammatory bowel disease. N. Engl. J. Med. 2002; 347: 417-29.
36. Lee AK, Sung SH, Kim YC, Kim SG. Inhibition of lipopolysaccharide- inducible nitric oxide synthase, TNF-alpha and COX-2 expression by sauchinone effects on IkappaBalpha phosphorylation, C/EBP and AP-1 activation. Br. J. Pharmacol. 2003; 139: 11-20.
37. Chen ZT, Li SL, Cai EQ, Wu WL, Jin JS, Zhu B. LPS induces pulmonary intravascular macrophages producing inflammatory mediators via activating NF-kappaB. J. Cell Biochem. 2003; 89: 1206-14.
38. Medzhitov R. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 2001; 1: 135-45.
39. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 1999; 274: 10689-92.